Faeth Therapeutics, Inc. (FTH)
34.50
-0.63
(-1.79%)
USD |
NASDAQ |
Sep 18, 16:00
34.47
-0.03
(-0.09%)
After-Hours: 20:00
Faeth Therapeutics Total Return Level : 34.50 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 34.50 |
| September 17, 2026 | 35.13 |
| September 16, 2026 | 34.24 |
| September 15, 2026 | 35.37 |
| September 14, 2026 | 39.09 |
| September 11, 2026 | 37.44 |
| September 10, 2026 | 39.00 |
| September 09, 2026 | 36.12 |
| September 08, 2026 | 39.20 |
| September 04, 2026 | 40.05 |
| September 03, 2026 | 39.00 |
| September 02, 2026 | 39.12 |
| September 01, 2026 | 34.51 |
| August 31, 2026 | 32.77 |
| August 28, 2026 | 33.84 |
| August 27, 2026 | 33.74 |
| August 26, 2026 | 32.97 |
| August 25, 2026 | 34.52 |
| August 24, 2026 | 34.71 |
| August 21, 2026 | 32.00 |
| August 20, 2026 | 32.10 |
| August 19, 2026 | 33.11 |
| August 18, 2026 | 33.00 |
| August 17, 2026 | 32.77 |
| August 14, 2026 | 32.34 |
| Date | Value |
|---|---|
| August 13, 2026 | 28.55 |
| August 12, 2026 | 29.38 |
| August 11, 2026 | 30.00 |
| August 10, 2026 | 28.57 |
| August 07, 2026 | 24.39 |
| August 06, 2026 | 24.48 |
| August 05, 2026 | 24.59 |
| August 04, 2026 | 25.50 |
| August 03, 2026 | 27.34 |
| July 31, 2026 | 27.24 |
| July 30, 2026 | 28.82 |
| July 29, 2026 | 28.93 |
| July 28, 2026 | 29.13 |
| July 27, 2026 | 29.24 |
| July 24, 2026 | 28.29 |
| July 23, 2026 | 27.76 |
| July 22, 2026 | 28.66 |
| July 21, 2026 | 28.37 |
| July 20, 2026 | 28.19 |
| July 17, 2026 | 25.87 |
| July 16, 2026 | 25.94 |
| July 15, 2026 | 31.47 |
| July 14, 2026 | 33.12 |
| July 13, 2026 | 33.36 |
| July 10, 2026 | 36.16 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Opus Genetics, Inc. | 5.18 |
| Perspective Therapeutics, Inc. | 2.88 |
| Praxis Precision Medicines, Inc. | 298.95 |
| Nuvectis Pharma, Inc. | 22.00 |
| Jade Biosciences, Inc. | 20.95 |